Oncolytic Virus Therapy Market

Global Oncolytic Virus Therapy Market Size study, by Type (Oncolytic Wild Type Viruses, Genetically Engineered Oncolytic Viruses), by Application (Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer) and Regional Forecasts 2018-2025

Report ID: BMRC 071 | Number of pages: 90 | Publish Date: Jan 2019 | Category: Lifesciences and Healthcare 
Global Oncolytic Virus Therapy Market to reach USD XX million by 2025.

Global Oncolytic Virus Therapy Market valued approximately USD XX million in 2017 is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The Oncolytic Virus Therapy Market is continuously growing across the world over the coming years. The major driving factor of global oncolytic virus therapy market are rising adoption of diagnostic 	& therapeutics procedure and increase in the number of patients with cancers. The major restraining factor of global oncolytic virus therapy market are lack of awareness among users and new class of anticancer immunotherapy. Oncolytic virus therapy is a virus that preferentially infects and kills cancer cells are destroyed by oncolysis, they extract new infectious viral particles to destroy the remaining tumor. The oncolytic viruses conduct the twice functions as they are not causing only the destruction of cancer infected cells but also stimulate the host anti-tumor immune response & don’t allow the expansion of tumor cells. 
The regional analysis of Global Oncolytic Virus Therapy Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to well-developed healthcare infrastructure with massive investment in R&D of oncolytic virus immunotherapy. Europe also contributes a satisfactory growth in the global oncolytic Virus therapy market. Asia-Pacific is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2018-2025 due to increased government initiatives. 
The major market player included in this report are:
•	Biovex
•	Cell Genesys
•	Crusade Laboratories
•	Genelux Corporation
•	Lokon Pharma
•	Merck
•	MultiVir

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below: 

By Type:

o	Oncolytic Wild Type Viruses
o	Genetically Engineered Oncolytic Viruses

By Application:

o	Breast Cancer
o	Lung Cancer
o	Prostate Cancer
o	Melanoma
o	Brain Tumor
o	Blood Cancer

By Regions:
o	North America
o	U.S.
o	Canada
o	Europe
o	UK
o	Germany
o	Asia Pacific
o	China
o	India
o	Japan
o	Latin America
o	Brazil
o	Mexico
o	Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Oncolytic Virus Therapy Market in Market Study:

o	Key Consulting Companies & Advisors
o	Large, medium-sized, and small enterprises
o	Venture capitalists
o	Value-Added Resellers (VARs)
o	Third-party knowledge providers
o	Investment bankers
o	Investors
Interested in this report?
Get your sample now!
Download Sample 
TABLE OF CONTENTS

Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
1.3.1.	Oncolytic Virus Therapy Market, by Type, 2015-2025 (USD Billion)
1.3.2.	Oncolytic Virus Therapy Market, by Application, 2015-2025 (USD Billion)
1.3.3.	Oncolytic Virus Therapy Market, by Region, 2015-2025 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Oncolytic Virus Therapy Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Oncolytic Virus Therapy Market Dynamics
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Oncolytic Virus Therapy Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Value Chain Analysis
4.3.1.	Supplier
4.3.2.	Manufacturers/Service Provider
4.3.3.	Distributors
4.3.4.	End-Users
4.4.	Key Buying Criteria
4.5.	Regulatory Framework
4.6.	Cost Structure Analysis
4.6.1.	Raw Material Cost Analysis
4.6.2.	Manufacturing Cost Analysis
4.6.3.	Labour Cost Analysis 
4.7.	Investment Vs Adoption Scenario
4.8.	Analyst Recommendation & Conclusion
Chapter 5.	Oncolytic Virus Therapy Market, by Type
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Key Market Players
5.4.	Oncolytic Virus Therapy Market, Sub Segment Analysis
5.4.1.	Oncolytic Wild Type Viruses
5.4.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.1.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.	Genetically Engineered Oncolytic Viruses
5.4.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
5.4.2.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6.	Oncolytic Virus Therapy Market, by Application
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Key Market Players
6.4.	Oncolytic Virus Therapy Market, Sub Segment Analysis
6.4.1.	Breast Cancer
6.4.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.1.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.	Lung Cancer
6.4.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.2.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.	Prostate Cancer
6.4.3.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.3.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.	Melanoma
6.4.4.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.4.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.	Brain Tumor
6.4.5.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.5.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.4.6.	Blood Cancer
6.4.6.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
6.4.6.2.	Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7.	Oncolytic Virus Therapy Market, by Regional Analysis
7.1.	Oncolytic Virus Therapy Market, Regional Market Snapshot (2015-2025)
7.2.	North America Oncolytic Virus Therapy Market Snapshot
7.2.1.	U.S.
7.2.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.1.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.	Canada
7.2.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.2.2.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.	Europe Oncolytic Virus Therapy Market  Snapshot
7.3.1.	U.K. 
7.3.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.	Germany 
7.3.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.	France 
7.3.3.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.	Rest of Europe
7.3.4.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.4.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.	Asia Oncolytic Virus Therapy Market Snapshot
7.4.1.	China 
7.4.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.1.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.	India 
7.4.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.2.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.	Japan
7.4.3.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.3.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.	Rest of Asia Pacific
7.4.4.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4.4.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.	Latin America Oncolytic Virus Therapy Market Snapshot
7.5.1.	Brazil 
7.5.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.1.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.	Mexico 
7.5.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5.2.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.	Rest of The World 
7.6.1.	South America
7.6.1.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.1.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.	Middle East and Africa
7.6.2.1.	Market estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.2.	Components breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.3.	Applications breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6.2.4.	End user breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8.	Competitive Intelligence
8.1.	Company Market Share (Subject to Data Availability)
8.2.	Top Market Strategies
8.3.	Company Profiles
8.3.1.	Biovex
8.3.1.1.	Overview
8.3.1.2.	Financial (Subject to Data Availability)
8.3.1.3.	Product Summary
8.3.1.4.	Recent Developments
8.3.2.	Cell Genesys
8.3.3.	Crusade Laboratories
8.3.4.	Genelux Corporation
8.3.5.	Lokon Pharma
8.3.6.	Merck
8.3.7.	MultiVir
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.1.6.	Research Assumption
TABLE 1.	LIST OF SECONDARY SOURCES, USED IN THE STUDY OF ONCOLYTIC VIRUS THERAPY MARKET
TABLE 2.	LIST OF PRIMARY SOURCES, USED IN THE STUDY OF ONCOLYTIC VIRUS THERAPY MARKET
TABLE 3.	ONCOLYTIC VIRUS THERAPY MARKET, REPORT SCOPE
TABLE 4.	YEARS CONSIDERED FOR THE STUDY
TABLE 5.	EXCHANGE RATES CONSIDERED
TABLE 6.	ONCOLYTIC VIRUS THERAPY MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7.	ONCOLYTIC VIRUS THERAPY MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
TABLE 8.	ONCOLYTIC VIRUS THERAPY MARKET ESTIMATES & FORECASTS BY TYPE 2015-2025 (USD BILLION)
TABLE 9.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 10.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 36.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 37.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 38.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 40.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 41.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 42.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 44.	ONCOLYTIC VIRUS THERAPY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 45.	U.S. ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 46.	U.S. ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 47.	U.S. ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48.	U.S. ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49.	U.S. ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50.	CANADA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51.	CANADA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52.	CANADA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53.	CANADA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54.	CANADA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 55.	UK ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 56.	UK ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57.	UK ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58.	UK ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 59.	UK ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60.	GERMANY ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 61.	GERMANY ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62.	GERMANY ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 63.	GERMANY ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64.	GERMANY ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65.	ROE ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 66.	ROE ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 67.	ROE ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68.	ROE ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69.	ROE ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 70.	CHINA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 71.	CHINA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72.	CHINA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73.	CHINA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 74.	CHINA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75.	INDIA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 76.	INDIA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77.	INDIA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 78.	INDIA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79.	INDIA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80.	JAPAN ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 81.	JAPAN ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 82.	JAPAN ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 83.	JAPAN ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 84.	JAPAN ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 85.	ROAPAC ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 86.	ROAPAC ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 87.	ROAPAC ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 88.	ROAPAC ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 89.	ROAPAC ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 90.	BRAZIL ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 91.	BRAZIL ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 92.	BRAZIL ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 93.	BRAZIL ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 94.	BRAZIL ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 95.	MEXICO ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 96.	MEXICO ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 97.	MEXICO ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 98.	MEXICO ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 99.	MEXICO ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 100.	ROLA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 101.	ROLA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 102.	ROLA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 103.	ROLA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 104.	ROLA ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 105.	ROW ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 106.	ROW ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 107.	ROW ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 108.	ROW ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 109.	ROW ONCOLYTIC VIRUS THERAPY MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
FIG 1.	ONCOLYTIC VIRUS THERAPY MARKET, RESEARCH METHODOLOGY
FIG 2.	ONCOLYTIC VIRUS THERAPY MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3.	GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4.	ONCOLYTIC VIRUS THERAPY MARKET, KEY TRENDS 2016
FIG 5.	ONCOLYTIC VIRUS THERAPY MARKET, GROWTH PROSPECTS 2017-2025
FIG 6.	ONCOLYTIC VIRUS THERAPY MARKET, PORTERS 5 FORCE MODEL
FIG 7.	ONCOLYTIC VIRUS THERAPY MARKET, PEST ANALYSIS
FIG 8.	ONCOLYTIC VIRUS THERAPY MARKET, VALUE CHAIN ANALYSIS
FIG 9.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 10.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 11.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 12.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 13.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 14.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 15.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 16.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 17.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 18.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 19.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 20.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 21.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 22.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 23.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 24.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 25.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 26.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 27.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 28.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 29.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 30.	ONCOLYTIC VIRUS THERAPY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 31.	ONCOLYTIC VIRUS THERAPY MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 32.	NORTH AMERICA ONCOLYTIC VIRUS THERAPY MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 33.	EUROPE ONCOLYTIC VIRUS THERAPY MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 34.	ASIA PACIFIC ONCOLYTIC VIRUS THERAPY MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 35.	LATIN AMERICA ONCOLYTIC VIRUS THERAPY MARKETMARKET 2015 & 2025 (USD BILLON)
FIG 36.	ONCOLYTIC VIRUS THERAPY MARKET, COMPANY MARKET SHARE ANALYSIS (2016)